MoneyWorks4Me

Ipca Laboratories to consider interim dividend

17 Jan 2012 Evaluate

Ipca Laboratories has informed that a meeting of the board of directors of the company will be held on January 31, 2012, to consider unaudited financial results for 3rd quarter and nine months ended December 31, 2011 and 2nd Interim dividend for the financial year 2011-12.

The above information is part of the company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..